General Information of Drug (ID: DMT408C)

Drug Name
Imilecleucel-T
Indication
Disease Entry ICD 11 Status REF
Multiple sclerosis 8A40 Phase 2 [1]
Cross-matching ID
TTD ID
D07TJT

References

1 ClinicalTrials.gov (NCT01684761) Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis. U.S. National Institutes of Health.